Conrad A. Fung

An explanation and critique of taguchi's contributions to quality engineering

George E. P. Box, Søren Bisgaard, Conrad A. Fung · Quality and Reliability Engineering International · 1988 · 275 citations

Engineering, Industrial Engineering, Quality Management +12

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance

Jane R. Kenny, Diane Ramsden, David B. Buckley et al. · Drug Metabolism and Disposition · 2018 · 68 citations · Full text

Medicine, Pharmacology, Toxicology +15

QUALITY QUANDARIES∗ Is Your Robust Design Procedure Robust?

George E. P. Box, Conrad A. Fung · Quality Engineering · 1994 · 33 citations

Architecture, Design, Design Optimization +3

Perspectives from the Innovation and Quality Consortium Induction Working Group on Factors Impacting Clinical Drug-Drug Interactions Resulting from Induction: Focus on Cytochrome 3A Substrates

Diane Ramsden, Conrad A. Fung, Niresh Hariparsad et al. · Drug Metabolism and Disposition · 2019 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

Simon Wong, Diane Ramsden, Shannon Dallas et al. · Drug Metabolism and Disposition · 2020 · 26 citations · Full text

Pharmacy, Pharmacology, Toxicology +17